Browse Category

Earnings Reports News 16 December 2025 - 17 December 2025

IES Holdings (IESC) Stock Drops on Dec. 17, 2025: What’s Driving the Move, Latest Earnings, Insider Sales, and Wall Street Forecasts

IES Holdings (IESC) Stock Drops on Dec. 17, 2025: What’s Driving the Move, Latest Earnings, Insider Sales, and Wall Street Forecasts

IES Holdings shares fell about 9% to $405 on Dec. 17, 2025, after opening above $446 and hitting an intraday high near $451. The drop followed a multi-year rally and came on lighter-than-usual volume. IES recently reported record fiscal 2025 results, with Q4 revenue up 16% to $898 million and net income up 61% to $101.8 million. Remaining performance obligations stood at $1.69 billion at year-end.
Xometry XMTR Stock Rallies on December 17 2025 as Earnings Momentum and Analyst Forecasts Stay in Focus

Xometry XMTR Stock Rallies on December 17 2025 as Earnings Momentum and Analyst Forecasts Stay in Focus

Xometry shares rose about 6% to $64.66 on Wednesday, bucking declines in major U.S. indexes. The move followed strong Q3 results showing 28% revenue growth and improved adjusted EBITDA, despite ongoing GAAP losses. Trading volume was below average as the stock appeared on top gainers lists. Xometry’s market cap stood near $3.1 billion.
The Toro Company (TTC) Stock Surges After Q4 FY2025 Earnings Beat and FY2026 Guidance — What Investors Are Watching

The Toro Company (TTC) Stock Surges After Q4 FY2025 Earnings Beat and FY2026 Guidance — What Investors Are Watching

Toro Company shares rose 9% to $79.43 by midafternoon December 17 after Q4 and full-year results topped analyst estimates. Q4 net sales fell 1% to $1.07 billion, with adjusted EPS at $0.91. Full-year net sales slipped 2% to $4.51 billion, but record free cash flow reached $578 million. Management issued 2026 guidance projecting renewed sales growth and highlighted the integration of Tornado Infrastructure Equipment.
Lennar Stock (NYSE: LEN) Slides After Q4 2025 Earnings Miss: 2026 Guidance, Analyst Targets, and What Investors Are Watching

Lennar Stock (NYSE: LEN) Slides After Q4 2025 Earnings Miss: 2026 Guidance, Analyst Targets, and What Investors Are Watching

Lennar shares fell over 4% in after-hours trading after the company reported weaker-than-expected earnings and soft guidance for early 2026, despite revenue beating forecasts. Fourth-quarter diluted EPS was $1.93 on $9.37 billion revenue, with gross margin on home sales dropping to 17%. The stock closed at $117.57, about 20% below its 52-week high. Lennar cited heavy use of incentives and mortgage-rate buydowns.
Micron Technology (MU) Stock News Today (Dec. 17, 2025): Earnings Loom, Analyst Targets Jump to $300+, and the Memory Price Boom Tests the Rally

Micron Technology (MU) Stock News Today (Dec. 17, 2025): Earnings Loom, Analyst Targets Jump to $300+, and the Memory Price Boom Tests the Rally

Micron Technology will report fiscal Q1 2026 results after markets close on December 17, with consensus forecasts at $12.9 billion revenue and $3.96 adjusted EPS. Shares traded near $232.51 Wednesday amid high expectations and recent price target hikes to $300. Options markets are pricing in a possible 9% stock move after earnings. Wall Street is also watching for next-quarter guidance, with forecasts at $14.3 billion revenue and $4.78 EPS.
Rezolve AI PLC (NASDAQ: RZLV) Stock News Today: $200M+ ARR Update Sparks Rally — Forecasts, Analyst Targets, and Key Risks (Dec. 17, 2025)

Rezolve AI PLC (NASDAQ: RZLV) Stock News Today: $200M+ ARR Update Sparks Rally — Forecasts, Analyst Targets, and Key Risks (Dec. 17, 2025)

Rezolve AI PLC expects December 2025 revenue to top $17 million and projects year-end annual recurring revenue above $200 million, according to a December 16 update. The company also anticipates positive adjusted EBITDA for the first time. Shares surged to $2.97, with trading and options volume spiking after the news.
Pfizer Stock (NYSE: PFE) News Today: 2026 Guidance, Earnings Forecasts, Analyst Price Targets and Key Catalysts

Pfizer Stock (NYSE: PFE) News Today: 2026 Guidance, Earnings Forecasts, Analyst Price Targets and Key Catalysts

Pfizer shares fell 3.4% to $25.53 late Dec. 16 after the company issued 2026 guidance projecting flat-to-declining revenue and adjusted EPS of $2.80–$3.00. The outlook cited lower COVID product sales and a $1.5 billion hit from patent expirations. Pfizer expects no share buybacks through 2026. Wall Street noted the EPS target is slightly below consensus.
Treasury Wine Estates (ASX:TWE) Stock Slides to 11-Year Low After 1H26 Earnings Outlook Cut, Buyback Cancellation and China/US Reset

Treasury Wine Estates (ASX:TWE) Stock Slides to 11-Year Low After 1H26 Earnings Outlook Cut, Buyback Cancellation and China/US Reset

Treasury Wine Estates shares plunged up to 16.8% to A$4.57, their lowest since January 2015, after the company warned of weaker near-term earnings and cancelled the rest of its share buyback. The Penfolds owner guided 1H26 EBITS to A$225–A$235 million, citing excess inventory in China and the US, and ongoing pricing pressure from parallel imports.
Tesla Stock (TSLA) After the Bell Dec. 16, 2025: Record Close Near $490 on Robotaxi Momentum — What to Know Before Wednesday’s Open

Tesla Stock (TSLA) After the Bell Dec. 16, 2025: Record Close Near $490 on Robotaxi Momentum — What to Know Before Wednesday’s Open

Tesla shares closed at a record $489.88 Tuesday, up 3.1%, after CEO Elon Musk said the company is testing fully autonomous robotaxis without safety monitors. The stock touched an intraday high of $491.50 before slipping slightly in after-hours trading. Trading volume topped 105 million shares. Analyst price targets diverged, with Mizuho raising its target to $530 and Wedbush holding at $600.
Nike Stock (NKE) Today: New Analyst Calls, Earnings Forecasts, and What Wall Street Expects Ahead of Nike’s Dec. 18 Report

Nike Stock (NKE) Today: New Analyst Calls, Earnings Forecasts, and What Wall Street Expects Ahead of Nike’s Dec. 18 Report

Nike shares traded at $66.96 on December 16, down 1.2% ahead of its Q2 2026 earnings report due December 18. Options markets signal traders expect a 7–8% move after results. Analyst forecasts point to revenue of about $12.2 billion and EPS of $0.37, both down year over year. Wall Street remains split on the company’s turnaround prospects.
Dillard’s (DDS) Stock Today: Special Dividend Fallout, Q3 Results, and the Latest Analyst Forecasts (Dec. 16, 2025)

Dillard’s (DDS) Stock Today: Special Dividend Fallout, Q3 Results, and the Latest Analyst Forecasts (Dec. 16, 2025)

Dillard’s stock fell 4.9% Tuesday to $645.61 after hitting an all-time high near $742 on Dec. 11, 2025. The drop follows a surge driven by a $30 special dividend, payable Jan. 5 to holders as of Dec. 12. In Q3, Dillard’s reported net sales of $1.469 billion and net income of $129.8 million, both up from a year earlier.
Accenture (ACN) Stock News Today: Morgan Stanley Upgrade, DLB Data Center Deal, and What to Watch Ahead of Earnings

Accenture (ACN) Stock News Today: Morgan Stanley Upgrade, DLB Data Center Deal, and What to Watch Ahead of Earnings

Morgan Stanley upgraded Accenture to Overweight on December 16, raising its price target to $320 and citing signs of demand recovery. Accenture also announced a deal to acquire a 65% stake in DLB Associates, expanding its data center footprint. Shares closed at $274.66 on December 15, still well below their February high. Early trading Tuesday showed a mixed reaction as investors weighed analyst optimism against execution risks.
ABIVAX Société Anonyme (ABVX) Stock News on Dec. 16, 2025: Shares Slide After Q3 Loss Widens, While Analysts Keep Buy Calls and M&A Talk Lingers

ABIVAX Société Anonyme (ABVX) Stock News on Dec. 16, 2025: Shares Slide After Q3 Loss Widens, While Analysts Keep Buy Calls and M&A Talk Lingers

Abivax shares fell about 5% in U.S. and Paris trading after reporting a nine-month net loss of €254.1 million, up from €136.9 million a year earlier. Cash and cash equivalents stood at €589.7 million as of September 30, expected to fund operations into Q4 2027. Investors weighed widening losses against a strong cash position and ongoing takeover speculation.
Navan (NAVN) Stock Sinks on Q3 Earnings and CFO Exit: Guidance, Analyst Price Targets, and Forecasts for 2026 (Dec. 16, 2025)

Navan (NAVN) Stock Sinks on Q3 Earnings and CFO Exit: Guidance, Analyst Price Targets, and Forecasts for 2026 (Dec. 16, 2025)

Navan shares fell 17%–18% by midday Tuesday after the company reported a larger-than-expected GAAP net loss and announced CFO Amy Butte will step down January 9, 2026. The stock has dropped over 40% since its IPO, cutting market value below $3 billion. Q3 revenue rose 29% to $195 million, but GAAP net loss reached $225 million, driven by $103 million in stock-based compensation and a $97 million debt extinguishment charge.
16 December 2025
Pfizer Stock (PFE) Slides After 2026 Guidance: COVID Sales Drop, Patent Cliff and Analyst Forecasts in Focus

Pfizer Stock (PFE) Slides After 2026 Guidance: COVID Sales Drop, Patent Cliff and Analyst Forecasts in Focus

Pfizer shares fell nearly 5% to about $25 in U.S. trading Tuesday after the company issued 2026 guidance with adjusted EPS of $2.80–$3.00, below Wall Street estimates. The stock reversed early gains as investors reacted to lower COVID-19 sales and patent expirations expected to pressure results next year. Trading volume topped 55 million shares by late morning.
Netskope Stock (NASDAQ: NTSK) Rebounds on Dec. 16, 2025 as Wall Street Weighs Earnings, Guidance, and Valuation

Netskope Stock (NASDAQ: NTSK) Rebounds on Dec. 16, 2025 as Wall Street Weighs Earnings, Guidance, and Valuation

Netskope, Inc. (NASDAQ: NTSK) stock is back in motion on December 16, 2025, rebounding after a sharp post-earnings slide that reminded investors of a simple truth about newly public, high-growth cybersecurity names: the fundamentals can be strong and the stock can still whip around like a drone in a wind tunnel. By late morning in U.S. trading, Netskope shares were changing hands around the $20 level—up roughly 7% on the day—after closing down 8.06% on Dec. 15. StockAnalysis+1 The tug-of-war now is clear: bulls point to accelerating subscription momentum (ARR and contracted backlog), improving non-GAAP margins, and new AI-era product
Johnson & Johnson Stock (JNJ) Today: FDA Priority Voucher, Talc Verdict, Earnings Date and 2026 Growth Outlook

Johnson & Johnson Stock (JNJ) Today: FDA Priority Voucher, Talc Verdict, Earnings Date and 2026 Growth Outlook

Johnson & Johnson shares fell about 1% to $211–$212 late Tuesday morning after hitting recent highs, following news that the FDA granted a National Priority Voucher for its Tecvayli and Darzalex combination therapy for multiple myeloma. The FDA highlighted strong Phase 3 results and rapid review plans. Investors await the company’s upcoming earnings update for further guidance.
Bank of America Stock (BAC) News Today: Near 20‑Year High, Rate‑Cut Bets Shift, and Analyst Forecasts Ahead of Q4 Earnings

Bank of America Stock (BAC) News Today: Near 20‑Year High, Rate‑Cut Bets Shift, and Analyst Forecasts Ahead of Q4 Earnings

Bank of America shares traded at $54.99 as of 16:10 UTC Tuesday, holding near their highest level since 2006. Investors weighed new U.S. jobs data showing nonfarm payrolls up 64,000 in November and a rise in the unemployment rate to 4.6%, which briefly raised odds of a January Fed rate cut. Bank of America’s overdraft and bounced-check fee income rose 2% in the first nine months of 2025.
GE Aerospace Stock (GE) Today: Citi’s $386 Target, FAA LEAP Directive, Dividend Date, and What to Watch Ahead of Q4 Earnings

GE Aerospace Stock (GE) Today: Citi’s $386 Target, FAA LEAP Directive, Dividend Date, and What to Watch Ahead of Q4 Earnings

GE Aerospace shares traded at $299.29, down 0.56% as of 11:00 a.m. EST Tuesday, with a market cap near $315.7 billion. Citi began coverage with a Buy rating and a $386 target, while BNP Paribas Exane started at Underperform with a $275 target. The FAA issued a new directive on LEAP-1A engine inspections, effective late December. GE declared a $0.36 dividend and set Q4 earnings for Jan. 22.
1 139 140 141 142 143 204

Stock Market Today

Wilmar (SGX:F34) share price slips as palm oil turns lower; what to watch next week

Wilmar (SGX:F34) share price slips as palm oil turns lower; what to watch next week

8 February 2026
Wilmar International shares fell 0.9% to S$3.44 on Friday as Singapore’s Straits Times Index slipped 0.8%. Malaysian palm oil futures posted their first weekly decline in five weeks ahead of industry events and data releases. The Malaysian Palm Oil Board will report January figures on Feb. 10. Wilmar’s full-year results are due Feb. 26.
Seatrium share price slips: what traders watch before SGX reopens Monday

Seatrium share price slips: what traders watch before SGX reopens Monday

8 February 2026
Seatrium shares closed down 1% at S$2.06 Friday ahead of full-year results due Feb. 26. The company marked a key offshore wind platform milestone with TenneT and GE Vernova this week. Investors are watching for updates on project progress, cash flow, and new orders as markets reopen Monday.
CapitaLand Investment share price jumps into earnings week as 9CI closes at S$3.12

CapitaLand Investment share price jumps into earnings week as 9CI closes at S$3.12

8 February 2026
CapitaLand Investment shares closed up 1.3% at S$3.12 on Friday, outperforming the STI, which fell 0.83%. CapitaLand Integrated Commercial Trust reported a 16.4% rise in second-half distributable income to S$449 million and a 9.4% increase in distribution per unit. Full-year results for CapitaLand Investment are due Feb. 11. Markets are closed for the weekend.
Go toTop